X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1580) 1580
Publication (72) 72
Book Review (16) 16
Book / eBook (5) 5
Conference Proceeding (2) 2
Magazine Article (2) 2
Web Resource (2) 2
Book Chapter (1) 1
Government Document (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1330) 1330
benzofurans - adverse effects (854) 854
male (819) 819
female (684) 684
middle aged (587) 587
amiodarone - adverse effects (559) 559
adult (483) 483
aged (464) 464
benzofurans - therapeutic use (432) 432
index medicus (424) 424
animals (364) 364
amiodarone - therapeutic use (238) 238
benzofurans - pharmacology (234) 234
polychlorinated dibenzodioxins - analogs & derivatives (208) 208
environmental sciences (187) 187
dibenzofurans, polychlorinated (175) 175
benzofurans - administration & dosage (169) 169
pharmacology & pharmacy (167) 167
arrhythmias, cardiac - drug therapy (160) 160
adolescent (134) 134
toxicology (134) 134
benzofurans - analysis (132) 132
dose-response relationship, drug (129) 129
rats (123) 123
time factors (113) 113
dioxins (107) 107
treatment outcome (107) 107
benzofurans - pharmacokinetics (103) 103
amiodarone - administration & dosage (94) 94
electrocardiography (94) 94
benzofurans - toxicity (92) 92
polychlorinated dibenzodioxins - analysis (92) 92
tachycardia - drug therapy (92) 92
dioxin (90) 90
double-blind method (88) 88
mice (88) 88
risk assessment (87) 87
polychlorinated dibenzodioxins - adverse effects (85) 85
public, environmental & occupational health (79) 79
benzofurans - chemistry (77) 77
child (77) 77
benzofurans - blood (76) 76
dibenzofurans (76) 76
toxicity (74) 74
hyperthyroidism - chemically induced (73) 73
research (73) 73
polychlorinated biphenyls (68) 68
drug interactions (66) 66
double-blind (65) 65
follow-up studies (65) 65
young adult (65) 65
pcbs (64) 64
polychlorinated biphenyls - analysis (63) 63
research article (63) 63
analysis (61) 61
polychlorinated biphenyls - adverse effects (61) 61
polychlorinated dibenzodioxins - toxicity (60) 60
pregnancy (60) 60
dibenzo-p-dioxins (59) 59
medicine, general & internal (59) 59
administration, oral (56) 56
benzofurans - metabolism (56) 56
environmental exposure (55) 55
health aspects (55) 55
pulmonary fibrosis - chemically induced (55) 55
benzofurans (53) 53
constipation - drug therapy (52) 52
gastroenterology & hepatology (52) 52
aged, 80 and over (50) 50
food contamination (50) 50
polychlorinated-biphenyls (50) 50
safety (50) 50
exposure (49) 49
hypothyroidism - chemically induced (48) 48
infant (47) 47
risk factors (47) 47
care and treatment (46) 46
clinical trials (46) 46
infant, newborn (45) 45
pigmentation disorders - chemically induced (45) 45
amiodarone - pharmacology (44) 44
coronary disease - drug therapy (44) 44
efficacy (44) 44
thyroid gland - drug effects (44) 44
angina pectoris - drug therapy (43) 43
clinical trials as topic (43) 43
constipation (43) 43
dioxins - analysis (43) 43
kinetics (43) 43
lung diseases - chemically induced (43) 43
chronic disease (41) 41
drug therapy (41) 41
drugs (41) 41
neurosciences (41) 41
polychlorinated dibenzodioxins - blood (41) 41
environmental pollutants - adverse effects (40) 40
pharmacokinetics (40) 40
polychlorinated biphenyls - toxicity (40) 40
corneal diseases - chemically induced (39) 39
dioxins - adverse effects (39) 39
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1274) 1274
French (144) 144
German (46) 46
Spanish (36) 36
Italian (35) 35
Chinese (9) 9
Portuguese (9) 9
Russian (8) 8
Dutch (6) 6
Polish (6) 6
Czech (4) 4
Danish (4) 4
Hebrew (4) 4
Japanese (3) 3
Finnish (2) 2
Hungarian (2) 2
Norwegian (2) 2
Swedish (2) 2
Bulgarian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Annals of Internal Medicine, ISSN 0003-4819, 07/2015, Volume 163, Issue 1, pp. 1 - 13
Journal Article
Annals of Internal Medicine, ISSN 0003-4819, 06/2012, Volume 156, Issue 12, pp. 861 - 874
Background: Urinary incontinence (UI) in women adversely affects quality of life. Purpose: To conduct a systematic literature review of drugs for urgency UI in... 
OVERACTIVE BLADDER SYNDROME | MEDICINE, GENERAL & INTERNAL | DAILY TROSPIUM CHLORIDE | SELECTIVE RECEPTOR ANTAGONIST | QUALITY-OF-LIFE | PLACEBO-CONTROLLED TRIAL | RANDOMIZED CONTROLLED-TRIAL | SEXUALLY ACTIVE WOMEN | EXTENDED-RELEASE TOLTERODINE | ANTIMUSCARINIC AGENT SOLIFENACIN | PATIENT-REPORTED OUTCOMES | Cresols - therapeutic use | Benzilates | Humans | Muscarinic Antagonists - adverse effects | Cresols - adverse effects | Solifenacin Succinate | Pyrrolidines - adverse effects | Muscarinic Antagonists - therapeutic use | Phenylpropanolamine - adverse effects | Phenylpropanolamine - therapeutic use | Pyrrolidines - therapeutic use | Benzhydryl Compounds - adverse effects | Comparative Effectiveness Research | Quinuclidines - therapeutic use | Nortropanes - adverse effects | Mandelic Acids - therapeutic use | Tolterodine Tartrate | Female | Nortropanes - therapeutic use | Mandelic Acids - adverse effects | Benzhydryl Compounds - therapeutic use | Quinuclidines - adverse effects | Benzofurans - therapeutic use | Tetrahydroisoquinolines - adverse effects | Tetrahydroisoquinolines - therapeutic use | Benzofurans - adverse effects | Randomized Controlled Trials as Topic | Urinary Incontinence - drug therapy | Quality of Life | Urinary incontinence | Research | Demographic aspects | Drug therapy | Patient outcomes
Journal Article
Expert Review of Anti-Infective Therapy, ISSN 1478-7210, 2014, Volume 12, Issue 7, pp. 763 - 773
About 2% of the world's population is estimated to be chronically infected with hepatitis C virus (HCV). These chronic carriers are at risk of developing liver... 
Daclatasvir | MK-8742 | Ombitasvir | Interferon-free | Ledipasvir | MK-5172 | Asunaprevir | ABT-450 | Sofosbuvir | Dasabuvir | CONTROLLED-TRIAL | PLUS RIBAVIRIN | LIVER-TRANSPLANTATION | ombitasvir | asunaprevir | HCV INFECTION | daclatasvir | interferon-free | ledipasvir | sofosbuvir | SUSTAINED VIROLOGICAL RESPONSE | PROTEASE INHIBITOR | TREATMENT OPTIONS | GENOTYPE 1 INFECTION | PHARMACOLOGY & PHARMACY | dasabuvir | CHRONIC VIRAL-HEPATITIS | DISEASE PROGRESSION | Uridine Monophosphate - administration & dosage | Quinoxalines - adverse effects | Anilides - therapeutic use | Isoquinolines - adverse effects | Hepatitis C - drug therapy | Anilides - adverse effects | Humans | Imidazoles - administration & dosage | Benzofurans - administration & dosage | Carbamates - administration & dosage | Uracil - administration & dosage | Ribavirin - administration & dosage | Uridine Monophosphate - adverse effects | Imidazoles - therapeutic use | Hepatitis C - prevention & control | Quinoxalines - therapeutic use | Uridine Monophosphate - therapeutic use | Disease Eradication | Benzofurans - therapeutic use | Quinoxalines - administration & dosage | Antiviral Agents - therapeutic use | Imidazoles - adverse effects | Ribavirin - therapeutic use | Uracil - therapeutic use | Clinical Trials as Topic | Macrocyclic Compounds - adverse effects | Antiviral Agents - administration & dosage | Benzofurans - adverse effects | Macrocyclic Compounds - therapeutic use | Uracil - adverse effects | Anilides - administration & dosage | Sulfonamides - therapeutic use | Ribavirin - adverse effects | Antiviral Agents - adverse effects | Uridine Monophosphate - analogs & derivatives | Isoquinolines - therapeutic use | Sulfonamides - adverse effects | Carbamates - adverse effects | Macrocyclic Compounds - administration & dosage | Carbamates - therapeutic use | Hepacivirus | Isoquinolines - administration & dosage | Drug Combinations | Sulfonamides - administration & dosage | Uracil - analogs & derivatives
Journal Article
Annals of Internal Medicine, ISSN 0003-4819, 11/2016, Volume 165, Issue 9, pp. 625 - 634
Journal Article
Gut, ISSN 0017-5749, 09/2017, Volume 66, Issue 9, pp. 1611 - 1622
Journal Article
Current Medicinal Chemistry, ISSN 0929-8673, 04/2012, Volume 19, Issue 12, pp. 1846 - 1863
New-generation antidepressants are a heterogeneous class of drugs used in the treatment of depression and related disorders. This review deals with the first... 
Paroxetine | Antidepressants | Fluoxetine | Pharmacological properties | Selective serotonin reuptake inhibitors (SSRIs) | Therapeutic drug monitoring (TDM) | Vilazodone | Fluvoxamine | Sertraline | Chemical-clinical correlations | Citalopram | ELECTRON-CAPTURE DETECTION | POSTTRAUMATIC-STRESS-DISORDER | CHEMISTRY, MEDICINAL | BIOCHEMISTRY & MOLECULAR BIOLOGY | fluvoxamine | TANDEM MASS-SPECTROMETRY | pharmacological properties | OBSESSIVE-COMPULSIVE DISORDER | PERFORMANCE LIQUID-CHROMATOGRAPHY | chemical-clinical correlations | therapeutic drug monitoring (TDM) | fluoxetine | paroxetine | selective serotonin reuptake inhibitors (SSRIs) | PHARMACOLOGY & PHARMACY | MAJOR DEPRESSIVE DISORDER | PLACEBO-CONTROLLED TRIAL | NEW-GENERATION ANTIDEPRESSANTS | citalopram | TRANSPORTER BINDING PROFILE | vilazodone | sertraline | SOLID-PHASE EXTRACTION | Paroxetine - pharmacokinetics | Serotonin Uptake Inhibitors - pharmacokinetics | Fluoxetine - pharmacokinetics | Humans | Citalopram - adverse effects | Depressive Disorder - drug therapy | Paroxetine - therapeutic use | Sertraline - adverse effects | Paroxetine - adverse effects | Benzofurans - pharmacokinetics | Sertraline - pharmacokinetics | Vilazodone Hydrochloride | Sertraline - therapeutic use | Fluoxetine - therapeutic use | Piperazines - pharmacokinetics | Fluoxetine - adverse effects | Fluvoxamine - therapeutic use | Benzofurans - therapeutic use | Serotonin Uptake Inhibitors - therapeutic use | Fluvoxamine - pharmacokinetics | Serotonin Uptake Inhibitors - adverse effects | Piperazines - therapeutic use | Benzofurans - adverse effects | Depressive Disorder - metabolism | Fluvoxamine - adverse effects | Piperazines - adverse effects | Indoles - adverse effects | Citalopram - pharmacokinetics | Citalopram - therapeutic use | Indoles - pharmacokinetics | Indoles - therapeutic use | Drug Monitoring
Journal Article
Gastroenterology, ISSN 0016-5085, 2016, Volume 152, Issue 1, pp. 164 - 175.e4
Journal Article
Lancet, The, ISSN 0140-6736, 2012, Volume 379, Issue 9824, pp. 1403 - 1411
Journal Article
Journal Article